// App-Quantinova.ai

FRI0313 : EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE

Researchers

Presenter

  • R. Demetrio Pablo

Principal Investigators

  • P. Munoz

  • V. Calvo-Rio

  • L. Riancho-Zarrabeitia

  • M. Lopez-Hoyos

  • V.M. Martinez-Taboada

Medical Centers

  • Immunology, Hospital Universitario Marques de Valdecilla. IDIVAL. Facultad Medicina. UC, Santander, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Deep vein thrombosis

  • Venous thrombosis

  • Optic neuropathy

  • Dyslipidemia

  • Hypertension

  • Peripheral neuropathy

  • Stroke

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved